Andreas Strüngmann

Who is Andreas Strüngmann?

Andreas Strüngmann was born in Germany and founded generic drug maker Hexal AG in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making Sandoz the largest generic-drug company in the world.

He currently has residences in Tegernsee, Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.